International Liver Congress

The Take Home

The Take Home: International Liver Congress 2018

HCV Next, May/June 2018
Nancy S. Reau, MD
As we in the United States look ahead to Digestive Disease Week coming up and further to our fall meetings, the International Liver Congress gives us…
Editorial

International Liver Congress Offers Insight on the ‘Social Science’ of HCV

HCV Next, May/June 2018
Ira M. Jacobson, MD
This month’s issue has a very nice summary of the data on therapeutic regimens presented at the International Liver Congress by Nancy S. Reau
Meeting NewsVideo

Gilead focuses on combination therapy to treat NASH fibrosis

April 25, 2018
PARIS — In this exclusive interview from the International Liver Congress 2018, Mani Subramanian, PhD, discusses innovative approaches to…
Meeting NewsVideo

Gilead presents new data on treatments for NASH fibrosis at ILC2018

April 24, 2018
PARIS — In this exclusive interview from the International Liver Congress 2018, Mani Subramanian, PhD, provides an update on Gilead’s…
Meeting News

Reduction of autotaxin may decrease itch in cholestatic liver disease

April 24, 2018
PARIS — Reduced serum bile acids after treatment with the ileal bile acid transporter inhibitor A4250 correlated with reductions in autotaxin…
Meeting News

HCV point-of-care diagnostics remove barriers to care

April 23, 2018
Findings presented at the International Liver Congress suggest that point-of-care testing for hepatitis C virus infection in community clinics in…
Meeting NewsVideo

Patient-reported outcomes improve after HCV clearance, regardless of cirrhosis

April 23, 2018
PARIS —Chairman of the department of medicine at Inova Fairfax Hospital, Virginia, Zobair M. Younossi, MD, discusses results of two studies on…
Meeting NewsVideo

Real-world patient study confirms Mavyret efficacy for HCV

April 23, 2018
PARIS — Results from a real-world cohort of patients with hepatitis C treated with Mavyret showed a sustained virologic response of 97%…
Meeting News

Albumin predicts cirrhosis improvement after SVR with DAAs

April 20, 2018
PARIS — Rapid improvement in albumin levels after 4 weeks of treatment with direct-acting antivirals for hepatitis C significantly predicted…
Meeting NewsVideo

Zepatier for 8 weeks safe, effective for HCV genotypes 1b, 4

April 20, 2018
PARIS — In this exclusive interview from the International Liver Congress 2018, Christophe Hezode, MD, discusses positive study results from…